# Xilio Therapeutics, Inc.: Form 8-K, filed Jun 17, 2024

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2024-06-17
- Accepted by EDGAR: Jun 17, 2024, 20:06 ET
- Period: 2024-06-13
- Accession: 0001558370-24-009247
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000155837024009247/xlo-20240613x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000155837024009247/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000155837024009247/xlo-20240613x8k.htm

Filed Jun 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-009247. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.